To compare safety profile of therapy in patients with ulcerative colitis (UC) and Crohn disease (?D), receiving anti-inflammatory therapy, using
bone marrow-derived mesenchymal stromal cells (MSC) and standard therapy with 5-aminosalicylic acid (5-ASA), glucocorticosteroids (GCS) and
immunosuppressive agents (IS).
View Full Article: HERE
Go through the Journal: http://www.enlivenarchive.org/genetic-molecular-and-cellular-biology
Contact Us: genetics@enlivenarchive.org